Essity AB (publ) (ESSITY_A) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Essity Ab Class A.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.498 Good morning and welcome to Esri's presentation of the Q2 results. 00:00:05.498 -- 00:00:09.843 My name is Sandra Åberg, I'm Head of Investor Relations here at Essity. 00:00:09.843 -- 00:00:14.848 We will begin with a summary of the key business highlights from our CEO Ulrika 00:00:14.848 -- 00:00:19.974 Karlsrud, followed by the financials and a closer look at the key metrics 00:00:19.974 -- 00:00:25.120 presented by our CFO Fredrik Rystad. After that, we will have a Q&A 00:00:25.120 -- 00:00:29.725 session where you will have the possibility to engage directly with us. 00:00:29.725 -- 00:00:35.570 If you would like to ask a question, you just press star one on your telephone. 00:00:35.570 -- 00:00:42.567 With that, let me hand over to our CEO. Ulrika, welcome. 00:00:43.316 -- 00:00:45.340 Thank you, Sandra. 00:00:45.340 -- 00:00:50.665 And welcome also from my side to this presentation. 00:00:50.828 -- 00:00:55.574 We can summarize the quarter with that we delivered a positive organic sales growth and 00:00:55.574 -- 00:01:01.402 a result of 4.7 billion SEK. And the fact that we have this stable development 00:01:01.402 -- 00:01:06.409 in a quite challenging market environment is a testament to our resilience and to 00:01:06.409 -- 00:01:12.121 the strength of our broad portfolio of essential hygiene and health products. 00:01:12.121 -- 00:01:17.067 The organic sales growth that we delivered was close to 2%, 1.9% 00:01:17.067 -- 00:01:22.113 to be precise, and primarily driven by a strong pricing performance. 00:01:22.113 -- 00:01:27.320 We also grew very nicely in our strategic categories and segments, such 00:01:27.320 -- 00:01:33.147 as feminine care, incontinence care, retail, wound care, lymphology, 00:01:33.147 -- 00:01:36....